CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTION
The article details the issue of malignancy caused by human papilloma virus (HPV), as well as characteristics of this virus. Its genetic stability allows for efficient prevention of this pathology through vaccination. 2 vaccines, which are approved by the FDA end EMEA for use and are registered in R...
Main Authors: | E.V. Uvarova, Z.Kh. Kumykova |
---|---|
Format: | Article |
Language: | English |
Published: |
Paediatrician Publishers, LLC
2011-01-01
|
Series: | Pediatričeskaâ Farmakologiâ |
Online Access: | https://pf.spr-journal.ru/jour/article/view/742 |
Similar Items
-
CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTION
by: E.V. Uvarova, et al.
Published: (2011-01-01) -
CERVICAL CANCER IS NOT A CHILDREN'S ILLNESS, ISN'T IT?
by: E.V. Uvarova, et al.
Published: (2009-06-01) -
CERVICAL CANCER IS NOT A CHILDREN'S ILLNESS, ISN'T IT?
by: E.V. Uvarova, et al.
Published: (2009-06-01) -
VIRUS OF HUMAN PAPILLOMA. EPIDEMIOLOGY, LABORATORY DIAGNOSTICS AND PREVENTION OF PAPILLOMA VIRAL INFECTION
by: O. V. Narvskaya
Published: (2014-06-01) -
Vaccination: A Double Opportunity to Prevent Human Papilloma Virus Infection
by: Beatriz Chambel
Published: (2020-06-01)